Emboliner ® IDE Study 100 Patient Milestone

Emboliner ® IDE Study 100 Patient Milestone

The Emboliner "Protect the Head to Head" investigational device exemption (IDE) clinical trial has seen its one hundredth patient enrolled. Emboline, Inc. focuses on reducing stroke and ischemic damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR)....

Latest News

Cardiology

Approvals / Clearance

Clinical Studies / Trials